Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2

Drug Target Prediction Based on the Herbs Components: The Study on the Multitargets Pharmacological Mechanism of Qishenkeli Acting on the Coronary Heart Disease

(2012) Yong Wang et al.   Evidence-based Complementary and Alternative Medicine

Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury

(2011) Yanfei Qi et al.   EXPERIMENTAL PHYSIOLOGY

Angiotensin Receptor Blockers: Role in Hypertension Management, Cardiovascular Risk Reduction, and Nephropathy

(2011) Jan Basile et al.   SOUTHERN MEDICAL JOURNAL

ACE2 Overexpression Ameliorates Left Ventricular Remodeling and Dysfunction in a Rat Model of Myocardial Infarction

(2010) Yu Xia Zhao et al.   HUMAN GENE THERAPY

Analysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophy

(2010) Arunachal Chatterjee et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction

(2009) Zamaneh Kassiri et al.   Circulation-Heart Failure

Review: Renal protection by inhibition of the renin-angiotensin-aldosterone system

(2009) Tomas Berl   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Structure of Protein Interaction Networks and Their Implications on Drug Design

(2009) Takeshi Hase et al.   PLoS Computational Biology

Role of angiotensin II AT1 receptor activation in cardiovascular diseases

(2008) Sandrine Billet et al.   KIDNEY INTERNATIONAL